ID: ALA1778155

Max Phase: Preclinical

Molecular Formula: C40H75NO14

Molecular Weight: 794.03

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)CC(C)(C)O)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O

Standard InChI:  InChI=1S/C40H75NO14/c1-15-27-40(12,49)32(44)22(4)29(42)20(2)17-38(10,48)34(55-36-30(43)26(16-21(3)51-36)41(13)19-37(8,9)47)23(5)31(24(6)35(46)53-27)54-28-18-39(11,50-14)33(45)25(7)52-28/h20-34,36,42-45,47-49H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29+,30-,31+,32-,33+,34-,36+,38-,39-,40-/m1/s1

Standard InChI Key:  RFKAUOGLAMBBCJ-IIIUCYNOSA-N

Associated Targets(non-human)

Motilin receptor 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 794.03Molecular Weight (Monoisotopic): 793.5188AlogP: 1.72#Rotatable Bonds: 9
Polar Surface Area: 217.30Molecular Species: BASEHBA: 15HBD: 7
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.45CX Basic pKa: 9.50CX LogP: 1.93CX LogD: -0.17
Aromatic Rings: 0Heavy Atoms: 55QED Weighted: 0.17Np Likeness Score: 1.62

References

1. Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ..  (2011)  The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.,  21  (12): [PMID:21570844] [10.1016/j.bmcl.2011.04.078]

Source